Company intelligence / Profile preview

Hybrid Medical

Eden Prairie, Minnesota, United Stateshybridmedicalanimation.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hybrid Medical has developed an invention for the treatment of Peyronie’s disease, which affects 3%-9% of the adult male population worldwide. There is currently no dominant treatment for this condition. The company’s solution appears to be a novel device-based approach, but there are no details on clinical results or regulatory progress.

Therapeutic areas: Men's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Hybrid Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hybrid Medical.

Explore the full profile